-
Mashup Score: 0Lung Cancer Clinicians Reflect on Major Updates From American Society of Clinical Oncology Meeting | Docwire News - 12 hour(s) ago
The panel discusses key developments and advances in lung cancer treatment from the 2024 American Society of Clinical Oncology Annual Meeting.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9
The Institutional Review Board (IRB)-approved Pregnancy and Lung Cancer Registry, was launched by the Florez Lab in December 2023 to collect data from around the world.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
📰 ICYMI: Lauren Kiel and Rebekah Kaufman of the @Florez_Lab joined us at #WCLC24 to share insights from their presentation on the lab's Pregnancy and Lung Cancer Registry! ⭐ Don't miss this interview! ➡️ Watch now: https://t.co/aud20yG40k #lcsm #LungCancer https://t.co/1survQ2GJz
-
-
Mashup Score: 5Dr. Gadgeel Reflects on Progress in Lung Cancer at IASLC 2024 World Conference on Lung Cancer | Docwire News - 2 day(s) ago
Shirish M. Gadgeel, MD, of the Henry Ford Cancer Institute, reflects on the progress in lung cancer treatment during the IASLC 2024 World Conference on Lung Cancer.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 As the end of the year approaches, don't miss this interview with @ShirishGadgeel, who reflects on progress he's seen in lung cancer treatment during his career and his hopes for the future. ➡️ Watch now: https://t.co/am8PJsR69x #lcsm #NSCLC #SCLC https://t.co/jVmln9loG9
-
-
Mashup Score: 7
Eric Singhi, MD, a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center, shares key highlights in lung cancer from ASCO 2024.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 As 2024 wraps up, we're reflecting on this #ASCOLung interview with @lungoncdoc, who discusses why the meeting represented an "unprecedented moment" in lung cancer. ➡️ Watch the #ASCO24 interview here: https://t.co/fa3Ha9VkT0 #lcsm #NSCLC #SCLC https://t.co/MpgSTyaYPJ
-
-
Mashup Score: 9Phase II Trial Shows Decreased Lung Volume in NSCLC Heightens Pneumonitis Risk | Docwire News - 3 day(s) ago
In patients receiving nivolumab or nivolumab plus ipilimumab after CCRT, lung V20 > 23% was associated with an increased risk of grade 2 or greater pneumonitis.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 Lung V20 > 23% was associated with an increased risk of pneumonitis in patients receiving nivolumab or ipilimumab plus nivolumab after definitive CCRT, according to a study published in @IJROBP by a team from @IUScholars. ➡️ Read more: https://t.co/umSwgTglF6 #lcsm #radonc https://t.co/2sqCFaokjx
-
-
Mashup Score: 1Officials Provide Update on Datopotamab Deruxtecan Biologics License Application for NSCLC | Docwire News - 5 day(s) ago
A prior BLA for datopotamab deruxtecan has been voluntarily withdrawn and a new BLA has been submitted for US accelerated approval.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
📰 What's the latest on BLAs for Dato-Dxd in the US? 📋 Officials from Daiichi Sankyo and AstraZeneca recently provided updates. ➡️ Learn more: https://t.co/gQumlGVYuX #NSCLC #FDA #oncology #lcsm #LungCancer https://t.co/W2ljUHFPi7
-
-
Mashup Score: 4Florez Lab Launches #HearHer Campaign to Raise Awareness of Lung Cancer in Women | Docwire News - 5 day(s) ago
The Florez Lab has been spreading the message of #HearHer by conducting an extensive social media campaign and sending out #HearHer pins and associated informational cards.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
⭐ ICYMI: Angela Morabito and Courtney Mantz of @Florez_Lab joined us for an insightful interview on the lab's #HearHer campaign to raise awareness of lung cancer in women! ➡️ Watch now: https://t.co/FtsmVURgVT #LCAM #LungCancerAwarenessMonth #lcsm https://t.co/2R5dUT5blJ
-
-
Mashup Score: 1American Lung Association Weighs In On Surgeon General’s Report on Tobacco Disparities | Docwire News - 5 day(s) ago
The US Surgeon General recently released the 35th Surgeon General’s Report on tobacco, titled “Eliminating Tobacco-Related Disease and Death: Addressing Disparities.”
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 Officials from the @LungAssociation are weighing in on the new @Surgeon_General's report on tobacco, which is titled “Eliminating Tobacco-Related Disease and Death: Addressing Disparities.” ➡️ Learn more: https://t.co/UBtkhriWGr https://t.co/BqT0C3uRbs
-
-
Mashup Score: 2Panel Shares Management Considerations for Patients Undergoing NSCLC Treatment | Docwire News - 6 day(s) ago
The panel discusses how to manage and counsel patients about adverse events and toxicities related to treatment for NSCLC, as well as the importance of a multidisciplinary team.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 What are the key management considerations when it comes to NSCLC? 💡 Don't miss this roundtable discussion on the topic, which features @DasMillie11, @LealTiciana, @DoctorDietrich, and Kent Shih, MD. ➡️ Watch now: https://t.co/A0tPIMT019 #lcsm #NSCLC #lungcancer https://t.co/W55zW0pRBp
-
-
Mashup Score: 1How Socioeconomic Factors Impact Surgical Care for US Veterans With Early-Stage NSCLC | Docwire News - 7 day(s) ago
Though veterans with high socioeconomic deprivation experience less than optimal surgical care, they do not experience inferior long-term outcomes after surgery for NSCLC.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
🫁 How do socioeconomic factors affect care and surgical outcomes for veterans with NSCLC? 📰 A new study by a team from @WUSTL provided insights and key action items. ➡️ Learn more: https://t.co/yULaGnbLvZ #lcsm #LungCancer #NSCLC https://t.co/4PAh7ITbOL
-
📰 Reflecting on this year's developments in lung cancer as 2024 winds down? 🫁 Don't miss this roundtable discussion on #NSCLC, which features key insights from @DasMillie11, @LealTiciana, @DoctorDietrich, and Kent Shih, MD. ➡️ Watch: https://t.co/zwStbRaebo #lcsm https://t.co/PDoO5nYKLk